Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Sleep Behaviors in Pregnancy 12/19/2019 INTERVENTIONAL unchanged 2,442.85 0 iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes 12/20/2019 INTERVENTIONAL unchanged 2,441.85 0 An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen 12/20/2019 INTERVENTIONAL unchanged 2,441.85 0 Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study 12/23/2019 INTERVENTIONAL unchanged 2,438.85 0 Comparing Efficacy of Microwave Vs Embolization Treatment for Adenomyosis 12/23/2019 INTERVENTIONAL unchanged 2,438.85 0 Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model 12/30/2019 OBSERVATIONAL unchanged 2,431.85 0 Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer 12/30/2019 INTERVENTIONAL unchanged 2,431.85 0 A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer 01/02/2020 INTERVENTIONAL unchanged 2,428.85 0 A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study 01/02/2020 INTERVENTIONAL unchanged 2,428.85 0 A Study of the Use of Text Message Reminders to Take Palbociclib 01/02/2020 INTERVENTIONAL unchanged 2,428.85 0 PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer 01/07/2020 INTERVENTIONAL unchanged 2,423.85 0 Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry 01/07/2020 OBSERVATIONAL unchanged 2,423.85 0 A Randomized Controlled Study of Digitalized Cognitive Behavioral Intervention for Antenatal Depression 01/10/2020 INTERVENTIONAL unchanged 2,420.85 0 Self-sampling for Non-attenders to Cervical Cancer Screening 01/13/2020 INTERVENTIONAL unchanged 2,417.85 0 The Role of Proprioceptive Deficits, Psychosocial Factors and Inflammation in Pregnancy-related Pelvic Girdle Pain 01/13/2020 INTERVENTIONAL unchanged 2,417.85 0 Gastric Emptying of Water and Sports Drink in Labor 01/14/2020 INTERVENTIONAL unchanged 2,416.85 0 Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections. 01/18/2020 INTERVENTIONAL unchanged 2,412.85 0 GammaPod Dose Escalation Radiation for Early Stage Breast Cancer 01/21/2020 INTERVENTIONAL unchanged 2,409.85 0 Multimodal Analgesia Effect on Post Surgical Patient 01/27/2020 INTERVENTIONAL unchanged 2,403.85 0 Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection 01/27/2020 INTERVENTIONAL unchanged 2,403.85 0 Primary HPV-based Cervical Cancer Screening Algorithms in Botswana 01/27/2020 INTERVENTIONAL unchanged 2,403.85 0 Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer 01/28/2020 INTERVENTIONAL unchanged 2,402.85 0 The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women. 01/30/2020 INTERVENTIONAL unchanged 2,400.85 0 Adjustable Continence Therapy (ACT) for the Treatment of Female SUI 01/30/2020 INTERVENTIONAL unchanged 2,400.85 0 Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR) 01/31/2020 INTERVENTIONAL unchanged 2,399.85 0 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer 01/31/2020 INTERVENTIONAL unchanged 2,399.85 0 A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma 01/31/2020 INTERVENTIONAL unchanged 2,399.85 0 A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding 02/05/2020 OBSERVATIONAL unchanged 2,394.85 0 Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer 02/05/2020 INTERVENTIONAL unchanged 2,394.85 0 Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC 02/05/2020 OBSERVATIONAL unchanged 2,394.85 0 Impact of Estradiol on Endothelial Function in Peri-Menopausal Women 02/05/2020 INTERVENTIONAL unchanged 2,394.85 0 Improving Genetic Counseling for BRCA+ Mothers 02/06/2020 INTERVENTIONAL unchanged 2,393.85 0 DOvEEgene Fleur: New Uterine Sampling Tool 02/06/2020 OBSERVATIONAL unchanged 2,393.85 0 NeoRad Breast Cancer Study 02/07/2020 INTERVENTIONAL unchanged 2,392.85 0 AFT: Introduction of a Full Breast Reconstructive Method 02/10/2020 OBSERVATIONAL unchanged 2,389.85 0 Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer 02/10/2020 INTERVENTIONAL unchanged 2,389.85 0 Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC 02/12/2020 INTERVENTIONAL unchanged 2,387.85 0 Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer 02/12/2020 INTERVENTIONAL unchanged 2,387.85 0 Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women 02/13/2020 INTERVENTIONAL unchanged 2,386.85 0 Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer 02/13/2020 INTERVENTIONAL unchanged 2,386.85 0 Gestational Diabetes 02/17/2020 OBSERVATIONAL unchanged 2,382.85 0 Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer 02/17/2020 INTERVENTIONAL unchanged 2,382.85 0 Evaluation Between Surgical Therapy of Lipedema Compared to Complex Physical Decongestive Therapy (CDT) Alone 02/17/2020 INTERVENTIONAL unchanged 2,382.85 0 Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening 02/18/2020 INTERVENTIONAL unchanged 2,381.85 0 FemBloc® Permanent Contraception - Confirmation Feasibility Trial 02/18/2020 INTERVENTIONAL unchanged 2,381.85 0 Physician Optimised Post-partum Hypertension Treatment Trial 02/18/2020 INTERVENTIONAL unchanged 2,381.85 0 Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer 02/18/2020 INTERVENTIONAL unchanged 2,381.85 0 Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus 02/19/2020 INTERVENTIONAL unchanged 2,380.85 0 Ovarian Function Following Intraovarian Injection of PRP 02/20/2020 INTERVENTIONAL unchanged 2,379.85 0 Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy 02/20/2020 INTERVENTIONAL unchanged 2,379.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology